CIK 0000925741
- Non-accelerated filer
- Smaller reporting company
BioCardia, Inc.
Sign in to watch- Ticker
- BCDA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 232753988
- Phone
- +1 650-226-0123
- Business address
- 320 SOQUEL WAY, SUNNYVALE, CA, 94085
- Former names
- Tiger X Medical, Inc., Cardo Medical, Inc., CLICKNSETTLE COM INC, NAM CORP
- 4 Exercise or conversion Director acquired 567 shares (option exercise)
- 4 Exercise or conversion Director acquired 567 shares (option exercise)
- 4 Open-market buy President and CEO bought 4,000 shares at $3.67 ($14,676)
- 4 Open-market buy President and CEO bought 200 shares at $4.34 ($868)
- 4 Open-market buy President and CEO bought 200 shares at $3.99 ($798)
- 4 Open-market buy President and CEO bought 5,700 shares at an average $3.47 ($19,771)
- 4 Exercise or conversion Director acquired 3,594 shares (option exercise)
- 4 Exercise or conversion Director acquired 4,161 shares (option exercise)
- 4 Exercise or conversion Director acquired 3,594 shares (option exercise)
- 4 Exercise or conversion Director acquired 4,161 shares (option exercise)
- 4 Exercise or conversion Director acquired 3,594 shares (option exercise)
- 4 Exercise or conversion Director acquired 4,161 shares (option exercise)
- 4 Exercise or conversion Director acquired 4,161 shares (option exercise)
- 4 Conversion Chief Financial Officer acquired 16,871 shares (conversion)
- 4 Conversion Chief Medical Officer acquired 8,435 shares (conversion)
- 4 Conversion President and CEO acquired 67,484 shares (conversion)
- 4 Conversion Director acquired 16,871 shares (conversion)
- 4 Open-market buy Director bought 166,666 shares at $6.00 ($999,996)
- 4 Open-market buy President and CEO bought 600 shares at $8.71 ($5,223)
- 4 Open-market buy President and CEO bought 700 shares at an average $10.63 ($7,442)
Page 13 of 23 · 442 filings